Columbus, Ohio -- For more than 12 years, Dr. James Belknap has lead the way in laminitis research. His work is being rewarded with more work in the form of an $82,000 grant to continue his research on laminitis.
Columbus, Ohio
-- For more than 12 years, Dr. James Belknap has lead the way in laminitis research. His work is being rewarded with more work in the form of an $82,000 grant to continue his research on laminitis.
Considered one of the leading equine laminitis researchers in the world, Belknap, an associate professor of equine surgery in the Department of Veterinary Clinical Sciences at The Ohio State University, received the grant from the Barbaro Memorial Fund.
The new study, "Effect of Digital Hypothermia on Inflammatory Injury in Laminitis," is a two-year project funded by the National Thoroughbred Racing Association Charities - Barbaro Memorial Fund, established in memory of the 2006 Kentucky Derby winner Barbaro.In addition to his latest work, Belknap has been principal investigator on eight other laminitis research projects, totaling $1.5 million, funded by the USDA, Morris Animal Foundation and the Grayson Jockey Club Research Foundation.
He received his DVM from Colorado State University and has worked at Ohio State for four years as a surgeon.
FDA approves oral drug for broad canine protection against parasites
October 7th 2024Elanco's lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets (Credelio Quattro) provide a single monthly dose for protection against fleas, ticks, heartworms, roundworms, hookworms, and 3 species of tapeworm.
Read More